Catalyst Wire Dossier Catalyst Wire Dossier

Immune Globulin Intravenous (IGIV)

intravenous immunoglobulin · Grifols Therapeutics LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Globulin Intravenous (IGIV), covering 2015-09-10 to 2015-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]

See pricing